Guided Therapeutics Inc. (OTCMKTS:GTHP – Get Free Report)’s stock price fell 12.7% on Monday . The company traded as low as $0.2620 and last traded at $0.2620. 3,800 shares traded hands during mid-day trading, a decline of 64% from the average session volume of 10,586 shares. The stock had previously closed at $0.30.
Guided Therapeutics Trading Down 12.7%
The stock has a market capitalization of $24.08 million, a P/E ratio of -5.24 and a beta of 0.57. The stock’s 50-day moving average price is $0.40 and its two-hundred day moving average price is $0.31.
Guided Therapeutics Company Profile
Guided Therapeutics, Inc is a medical device company focused on the development and commercialization of non‐invasive optical diagnostic platforms for women’s health. Its flagship product, the LuViva® Advanced Cervical Scan, combines hyperspectral and reflectance imaging to support the early detection of cervical epithelial abnormalities. By capturing tissue fluorescence and reflectance signatures in real time, LuViva is designed to augment traditional visual inspection methods and assist clinicians during colposcopic evaluations.
The company secured 510(k) clearance from the U.S.
Featured Articles
- Five stocks we like better than Guided Therapeutics
- Gold Shock Coming March 18?
- Buy this Gold Stock Before May 15th, 2026
- America’s 1776 happening again
- J.P. Morgan is betting on this coin
- Central banks just did something they haven’t done since 1967
Receive News & Ratings for Guided Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Guided Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
